NCT03203876 A Safety Study of Lirilumab in Combination With Nivolumab or in Combination With Nivolumab and Ipilimumab in Advanced and/or Metastatic Solid Tumors Status COMPLETED Phase PHASE1
NCT03203473 Study of Optimized Management of Nivolumab Based on Response in Patients With Advanced RCC (OMNIVORE Study) Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03200977 Safety of Allogeneic Hematopoietic Cell Transplantation (HCT) For Patients With Classical Hodgkin Lymphoma (CHL) Treated With Nivolumab Status COMPLETED Phase N/A
NCT03199846 Treatment Patterns and Outcomes Study in Patients With Unresectable Stage III and Metastatic (Stage IV) Melanoma in the United States Status COMPLETED Phase N/A
NCT03198182 A Study to Test the Effects of BMS-986036 on the Body in Healthy Japanese and Non-Japanese Subjects Status COMPLETED Phase PHASE1
NCT03198013 A Study of Pharmacokinetics (PK) and Pharmacodynamics (PD) in Relation to Prednisolone in Healthy Males Status COMPLETED Phase PHASE1
NCT03197779 A Short and Long Intravenous Infusion Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-962212 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03196557 A Study to Assess the Pharmacodynamics (PD) of Prednisoline in Healthy Male Subject Status COMPLETED Phase PHASE1
NCT03196206 Evaluate Pharmacokinetics and Safety of BMS-986177 in Participants With Normal Renal Function and With Moderate or Severe Renal Impairment Status COMPLETED Phase PHASE1
NCT03195491 A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia Status COMPLETED Phase PHASE3
NCT03195478 A Study of Nivolumab in Combination With Ipilimumab in Chinese Participants With Previously Treated Advanced or Recurrent Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03192969 A Study to Evaluate Efficacy and Safety of Subcutaneous Abatacept With Steroid Treatment Compared to Steroid Treatment Alone in Adults With Giant Cell Arteritis (GCA) Status WITHDRAWN Phase PHASE3
NCT03192943 A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors Status COMPLETED Phase PHASE1
NCT03192215 AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke Status TERMINATED Phase PHASE3
NCT03190265 Study of CRS-207, Nivolumab, and Ipilimumab With or Without GVAX Pancreas Vaccine (With Cy) in Patients With Pancreatic Cancer Status COMPLETED Phase PHASE2
NCT03189069 A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage Status COMPLETED Phase N/A
NCT03188081 A Study to Investigate the Effectiveness of an Education Support Program on Medication Adherence in Italian Real Life Rheumatoid Arthritis (RA) Patients Treated With Subcutaneous (SC) Abatacept Status COMPLETED Phase N/A
NCT03184870 A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT03181074 Early Post-marketing Study of Daclatasvir (Daklinza) in the Treatment of Chronic Hepatitis C (CHC) in Adults Status COMPLETED Phase N/A
NCT03177239 Phase II Sequential Treatment Trial of Single Agent Nivolumab, Then Combination Ipilimumab + Nivolumab in Metastatic or Unresectable Non-Clear Cell Renal Cell Carcinoma (ANZUP1602) Status UNKNOWN Phase PHASE2